Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination

American Journal of Kidney Diseases

Volumn 32, Issue 6, 1998, Pages 1041-1045

  Propst, T ^a   Propst, A ^a   Lhotta, K ^a   Vogel, W ^a   Konig, P ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Hemodialysis; Hepatitis B virus infection; Intradermal hepatitis B vaccination; Intramuscular hepatitis B vaccination; Subcutaneous hepatitis B vaccination

Indexed keywords

HEPATITIS B VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; DIALYSIS; DRUG DELIVERY SYSTEM; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION PREVENTION; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VACCINATION;

EID: 0031796315     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(98)70081-2     Document Type: Article

References (22)